Morgens Waterfall Vintiadis & Co’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-50,000	Closed	-$1.11M	–	53
2019 Q2	$1.11M	Buy	+50,000	New	+$1.11M	0.76%	35